Inequalities in successful tobacco cessation and tobacco cessation attempts: Evidence from eight Sub-Saharan African countries.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 04 02 2022
accepted: 02 11 2022
entrez: 22 11 2022
pubmed: 23 11 2022
medline: 25 11 2022
Statut: epublish

Résumé

Tobacco consumption is a contributing and modifiable risk factor for non-communicable diseases. In high-income countries, tobacco cessation attempts, and their success, are concentrated among the socio-economically advantaged, resulting in a skewed burden of disease. However, there is a paucity of evidence on the distribution of tobacco cessation in low- and middle-income countries. The objective of this study is to measure and decompose wealth- and education-related inequalities in tobacco cessation in eight Sub-Saharan African countries. The study applies Erreygers' corrected concentration indices and decomposition methods to the most recent Global Adult Tobacco Surveys in Botswana, Cameroon, Ethiopia, Kenya, Nigeria, Senegal, Tanzania, and Uganda. We find that across countries, successful tobacco cessation, as well as tobacco cessation attempts, are concentrated among wealthier and better-educated individuals. Differences in socio-economic status, urban or rural residence, and not knowing or believing that tobacco consumption leads to serious illness contributes to these inequalities. Governments in our sample of countries can do more to support socio-economically disadvantaged smokers in their efforts to quit smoking, including by making an effort to align each country's smoking cessation strategy with the guidelines outlined in the World Health Organization's Framework Convention on Tobacco Control.

Sections du résumé

BACKGROUND
Tobacco consumption is a contributing and modifiable risk factor for non-communicable diseases. In high-income countries, tobacco cessation attempts, and their success, are concentrated among the socio-economically advantaged, resulting in a skewed burden of disease. However, there is a paucity of evidence on the distribution of tobacco cessation in low- and middle-income countries.
OBJECTIVE
The objective of this study is to measure and decompose wealth- and education-related inequalities in tobacco cessation in eight Sub-Saharan African countries.
METHODOLOGY
The study applies Erreygers' corrected concentration indices and decomposition methods to the most recent Global Adult Tobacco Surveys in Botswana, Cameroon, Ethiopia, Kenya, Nigeria, Senegal, Tanzania, and Uganda.
FINDINGS
We find that across countries, successful tobacco cessation, as well as tobacco cessation attempts, are concentrated among wealthier and better-educated individuals. Differences in socio-economic status, urban or rural residence, and not knowing or believing that tobacco consumption leads to serious illness contributes to these inequalities.
CONCLUSION
Governments in our sample of countries can do more to support socio-economically disadvantaged smokers in their efforts to quit smoking, including by making an effort to align each country's smoking cessation strategy with the guidelines outlined in the World Health Organization's Framework Convention on Tobacco Control.

Identifiants

pubmed: 36413527
doi: 10.1371/journal.pone.0277702
pii: PONE-D-22-03498
pmc: PMC9681111
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0277702

Informations de copyright

Copyright: © 2022 Rossouw, Filby. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Int J Equity Health. 2019 Jan 11;18(1):6
pubmed: 30634985
Tob Prev Cessat. 2021 Jun 25;7:47
pubmed: 34222728
Tob Induc Dis. 2017 Nov 02;15:41
pubmed: 29142531
Addiction. 2008 Mar;103(3):502-8
pubmed: 18269370
J Epidemiol. 2020 Mar 5;30(3):136-142
pubmed: 30828035
J Health Econ. 2009 Mar;28(2):516-20, author reply 521-4
pubmed: 19167117
J Epidemiol Community Health. 2015 Sep;69(9):886-92
pubmed: 25841241
BMC Womens Health. 2014 Dec 12;14:156
pubmed: 25495192
Biomed Res Int. 2015;2015:274056
pubmed: 26273602
BMC Public Health. 2020 Mar 4;20(1):289
pubmed: 32131787
Health Psychol. 2010 May;29(3):262-73
pubmed: 20496980
Tob Control. 2012 Nov;21(6):536-42
pubmed: 21972062
BMC Res Notes. 2010 Mar 04;3:57
pubmed: 20199691
J Public Health Afr. 2015 Aug 17;6(2):523
pubmed: 28299144
Nicotine Tob Res. 2017 Nov 07;19(12):1401-1407
pubmed: 27679607
BMJ Open. 2014 Dec 22;4(12):e006414
pubmed: 25534212
J Multidiscip Healthc. 2020 Jul 27;13:693-707
pubmed: 32801732
PLoS One. 2019 Sep 6;14(9):e0220223
pubmed: 31490958
PLoS One. 2019 Jan 30;14(1):e0211208
pubmed: 30699173
Soc Sci Med. 1991;33(5):545-57
pubmed: 1962226
J Bras Pneumol. 2009 Dec;35(12):1198-203
pubmed: 20126921
Tob Control. 1997;6 Suppl 2:S57-62
pubmed: 9583654
Tob Induc Dis. 2015 Aug 11;13(1):23
pubmed: 26261450
Eur Urol Focus. 2015 Aug;1(1):3-16
pubmed: 28723352
Cad Saude Publica. 2013 Mar;29(3):485-95
pubmed: 23532284
Health Policy Plan. 2016 Nov;31(9):1212-24
pubmed: 27208896
Nicotine Tob Res. 2010 Jun;12(6):647-57
pubmed: 20439385
Fam Med Community Health. 2021 Jan;9(1):
pubmed: 33431587
Tob Control. 2018 Jan;27(1):58-64
pubmed: 28138063
Addict Behav. 2014 Sep;39(9):1304-10
pubmed: 24836161
J Health Econ. 2009 Mar;28(2):504-15
pubmed: 18367273
Prev Med. 2019 Jun;123:143-151
pubmed: 30902700

Auteurs

Laura Rossouw (L)

School of Economics and Finance, Faculty of Commerce, Law and Management, University of the Witwatersrand, Johannesburg, South Africa.

Samantha Filby (S)

Samantha Filby, Research on the Economics of Excisable Products, School of Economics, University of Cape Town, Rondebosch, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH